The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer
Clinical trial NCT02380196 · COMPLETED
Trial details
- NCT number
- NCT02380196
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-03-01
- Primary completion
- 2019-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.